Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - DEPRECIATION & AMORTIZATION
Depreciation & Amortization PRPH - ProPhase Labs, Inc.
6.7 M
LAST VALUE
37.11%
2 YEAR CAGR
77.23%
5 YEAR CAGR
39.33%
10 YEAR CAGR